Effects of a pre-workout supplement on hyperemia following leg extension resistance exercise to failure with different resistance loads.

What Was Tested

The paper reports a study of Copper (Supplement), published as a randomized controlled trial.

Given the potential interaction with training loads/time-under-tension, the researchers evaluated the hyperemic response at two different loads to failure.

Who Took Part

The study group was 1, participants.

By PubMed's age tags, the people studied were young adults and adults, men only.

Repeated measures ANOVAs were performed with time, supplement, and load as independent variables and Bonferroni correction applied for multiple post-hoc comparisons.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

Blinding on both sides kept the participants and researchers unaware of who received Copper (Supplement).

A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.

Thirty males participated in this double-blinded study.

Heart rate (HR), blood pressure (BP), femoral artery blood flow, and plasma nitrate/nitrite (NOx) were assessed at baseline (BL), 45-min post-PWS/PBO consumption (PRE), and 5-min following the last set of leg extensions (POST).

Vastus lateralis near infrared spectroscopy (NIRS) was employed during leg extension exercise.

Data are reported as mean ± SD.

What Was Measured

Given the potential interaction with training loads/time-under-tension, the researchers evaluated the hyperemic response at two different loads to failure.

The subject headings attached to it are Dietary Supplements, Energy Metabolism, Femoral Artery, Healthy Volunteers, Heart Rate, Hyperemia and Leg.

The authors tagged it with the keywords Blood flow, Nitric oxide, Volume load, Oxygenation, Reactive hyperemia, Resistance exercise and Sports supplements.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Copper (Supplement) in 1, participants.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2017 (Journal of the International Society of Sports Nutrition), a journal based in United States.

More context: the Copper (Supplement) compound page, all human trials.